ADULT-ONSET STILL DISEASE
Clinical trials for ADULT-ONSET STILL DISEASE explained in plain language.
Never miss a new study
Get alerted when new ADULT-ONSET STILL DISEASE trials appear
Sign up with your email to follow new studies for ADULT-ONSET STILL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks ilaris use in rare inflammatory diseases across europe
Disease control Recruiting nowThis study looks at how patients with Familial Mediterranean Fever (FMF) and Still's disease (including systemic juvenile idiopathic arthritis and adult-onset Still's disease) use the drug canakinumab (Ilaris) over the long term. Researchers will track 160 patients across Europe …
Matched conditions: ADULT-ONSET STILL DISEASE
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
5,000 patients join Yale's quest to crack rheumatic disease mysteries
Knowledge-focused Recruiting nowThis study is building a large registry and biorepository of 5,000 adults with various rheumatic diseases like rheumatoid arthritis, lupus, and scleroderma. Researchers at Yale University will collect medical data and biological samples over time to better understand these condit…
Matched conditions: ADULT-ONSET STILL DISEASE
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC